BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8668343)

  • 1. Isolation and characterization of Nmi, a novel partner of Myc proteins.
    Bao J; Zervos AS
    Oncogene; 1996 May; 12(10):2171-6. PubMed ID: 8668343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN.
    Bannasch D; Weis I; Schwab M
    Oncogene; 1999 Nov; 18(48):6810-7. PubMed ID: 10597290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of interferon-inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain.
    Lee ND; Chen J; Shpall RL; Naumovski L
    J Interferon Cytokine Res; 1999 Nov; 19(11):1245-52. PubMed ID: 10574616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
    Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A divergent cDNA homologue of the c-myc proto-oncogene in the eastern oyster Crassostrea virginica: implications for Myc evolution.
    Marsh AG; Chen TT
    Mol Mar Biol Biotechnol; 1995 Jun; 4(2):185-92. PubMed ID: 7773336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D; Prendergast GC
    Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S
    Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-MYC: evidence for multiple regulatory functions.
    Penn LJ; Laufer EM; Land H
    Semin Cancer Biol; 1990 Feb; 1(1):69-80. PubMed ID: 2133113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein.
    Dang CV; McGuire M; Buckmire M; Lee WM
    Nature; 1989 Feb; 337(6208):664-6. PubMed ID: 2645525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.
    Huang A; Ho CS; Ponzielli R; Barsyte-Lovejoy D; Bouffet E; Picard D; Hawkins CE; Penn LZ
    Cancer Res; 2005 Jul; 65(13):5607-19. PubMed ID: 15994933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the c-Myc coiled coil with interfering peptides.
    Jouaux EM; Schmidtkunz K; Müller KM; Arndt KM
    J Pept Sci; 2008 Sep; 14(9):1022-31. PubMed ID: 18465834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
    Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
    FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX.
    Yuan J; Tirabassi RS; Bush AB; Cole MD
    Oncogene; 1998 Sep; 17(9):1109-18. PubMed ID: 9764821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
    Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X; Giap C; Lazo JS; Prochownik EV
    Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
    Ben-Yosef T; Yanuka O; Benvenisty N
    Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are myc proteins transcription factors?
    Collum RG; Alt FW
    Cancer Cells; 1990 Mar; 2(3):69-75. PubMed ID: 2202379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.